Cargando…

Eighty per cent more patients in 10 years of UK molecular radiotherapy: Internal Dosimetry Users Group survey results from 2007 to 2017

Detalles Bibliográficos
Autores principales: Rojas, Bruno, McGowan, Daniel R., Guy, Matthew J., Tipping, Jill, Aldridge, Matthew, Gear, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587230/
https://www.ncbi.nlm.nih.gov/pubmed/31058745
http://dx.doi.org/10.1097/MNM.0000000000001020
_version_ 1783429024827047936
author Rojas, Bruno
McGowan, Daniel R.
Guy, Matthew J.
Tipping, Jill
Aldridge, Matthew
Gear, Jonathan
author_facet Rojas, Bruno
McGowan, Daniel R.
Guy, Matthew J.
Tipping, Jill
Aldridge, Matthew
Gear, Jonathan
author_sort Rojas, Bruno
collection PubMed
description
format Online
Article
Text
id pubmed-6587230
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-65872302019-07-22 Eighty per cent more patients in 10 years of UK molecular radiotherapy: Internal Dosimetry Users Group survey results from 2007 to 2017 Rojas, Bruno McGowan, Daniel R. Guy, Matthew J. Tipping, Jill Aldridge, Matthew Gear, Jonathan Nucl Med Commun Editorial Lippincott Williams & Wilkins 2019-07 2019-05-02 /pmc/articles/PMC6587230/ /pubmed/31058745 http://dx.doi.org/10.1097/MNM.0000000000001020 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (http://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/
spellingShingle Editorial
Rojas, Bruno
McGowan, Daniel R.
Guy, Matthew J.
Tipping, Jill
Aldridge, Matthew
Gear, Jonathan
Eighty per cent more patients in 10 years of UK molecular radiotherapy: Internal Dosimetry Users Group survey results from 2007 to 2017
title Eighty per cent more patients in 10 years of UK molecular radiotherapy: Internal Dosimetry Users Group survey results from 2007 to 2017
title_full Eighty per cent more patients in 10 years of UK molecular radiotherapy: Internal Dosimetry Users Group survey results from 2007 to 2017
title_fullStr Eighty per cent more patients in 10 years of UK molecular radiotherapy: Internal Dosimetry Users Group survey results from 2007 to 2017
title_full_unstemmed Eighty per cent more patients in 10 years of UK molecular radiotherapy: Internal Dosimetry Users Group survey results from 2007 to 2017
title_short Eighty per cent more patients in 10 years of UK molecular radiotherapy: Internal Dosimetry Users Group survey results from 2007 to 2017
title_sort eighty per cent more patients in 10 years of uk molecular radiotherapy: internal dosimetry users group survey results from 2007 to 2017
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587230/
https://www.ncbi.nlm.nih.gov/pubmed/31058745
http://dx.doi.org/10.1097/MNM.0000000000001020
work_keys_str_mv AT rojasbruno eightypercentmorepatientsin10yearsofukmolecularradiotherapyinternaldosimetryusersgroupsurveyresultsfrom2007to2017
AT mcgowandanielr eightypercentmorepatientsin10yearsofukmolecularradiotherapyinternaldosimetryusersgroupsurveyresultsfrom2007to2017
AT guymatthewj eightypercentmorepatientsin10yearsofukmolecularradiotherapyinternaldosimetryusersgroupsurveyresultsfrom2007to2017
AT tippingjill eightypercentmorepatientsin10yearsofukmolecularradiotherapyinternaldosimetryusersgroupsurveyresultsfrom2007to2017
AT aldridgematthew eightypercentmorepatientsin10yearsofukmolecularradiotherapyinternaldosimetryusersgroupsurveyresultsfrom2007to2017
AT gearjonathan eightypercentmorepatientsin10yearsofukmolecularradiotherapyinternaldosimetryusersgroupsurveyresultsfrom2007to2017